Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.32 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.32 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27245070 | 0.88 | MEN1 (0.35) | OPRM1OPRK1MAPT | |
| SCHEMBL30890578 | 0.88 | MEN1 (0.35) | OPRM1OPRK1MAPT | |
| SCHEMBL30890459 | 0.87 | AAK1 (0.34) | OPRM1OPRK1HDAC8DPP4DPP8 | |
| SCHEMBL27245190 | 0.86 | MAPT (0.32) | OPRM1OPRK1MAPT | |
| SCHEMBL27245200 | 0.86 | MAPT (0.32) | OPRM1OPRK1MAPT | |
| SCHEMBL27245135 | 0.82 | MEN1 (0.32) | OPRM1OPRK1MAPT | |
| SCHEMBL27245138 | 0.82 | MEN1 (0.32) | OPRM1OPRK1MAPT | |
| Trifluoroacetic Acid SCHEMBL27245083 | 0.82 | OPRM1 (0.32) | OPRM1OPRK1POLBHSD17B10 | |
| SCHEMBL30890486 | 0.81 | CTSK (0.46) | — | |
| SCHEMBL25656362 | 0.80 | BACE1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |